BUSINESS STANDARDS
is the quarterly magazine of BSI Group, highlighting the vital role that standards play in today's business environment. Regular features include interviews with leading business figures, as well as news on the latest developments in management systems and standards.
The hard cell
14 Feb 2007
Topics: Stem cell
Few areas of science prompt as much controversy as cell-based therapies - if only because stem-cell research falls into this category - but their potential seems extraordinary. For example, in theory, cells could be taken from a patient's immune system and manipulated to increase their effectiveness, and then re-introduced into the patient's system. If it works, cell-based therapies could play a major role in fighting everything from AIDS to cancer.
However, most of these therapies are still at the earliest stage and there remain significant obstacles to overcome. First and foremost, there has not been clear guidance of what regulation exists at all, if any, for businesses and academia hoping to commercialize any discoveries related to cell-based therapy. This is why the Department of Trade and Industry (DTI) commissioned BSI British Standards to develop PAS 83 Guidance on codes of practice, standardized methods and regulations for cell-based therapeutics - from basic research to clinical application.
"PAS 83 highlights any relevant legislation and guidance surrounding cell-based therapies including stem cells. There are some grey areas in the legislation which the PAS helps to clarify," says Simon Alcock, committee manager with BSI British Standards. "In Europe, products are currently classified as medical devices or as medicinal products, but no European Directives deal specifically with cell-based therapies. A new EU Directive for advanced therapy medicinal products including stem cell products is being drafted, but the UK industry needed guidance on best practice right now."
The guide has been produced to define and capture the key stages in a product lifecycle, from cell/tissue procurement through to commercialization and post-launch requirements.
"The UK is a favourable environment in which to do stem cell research and PAS 83 has had input from key stakeholders, including the UK regulators who are directly involved with the development of European Directives in this area," Alcock continues.
"There's a good base of academic research going on and PAS 83 helps them better understand how they can commercialize their products. At its heart, PAS 83 is promoting best practice in the industry and it is hoped that the PAS will help this important UK industry to grow," he says.
For more information, visit:
www.bsi-global.com/feb07pas83
Business Standards © 2009. Editorial produced by Caspian Publishing in association with the British Standards Institution. Editorial opinions expressed on are not necessarily those of BSI Group or Caspian Publishing. Neither Caspian Publishing nor BSI Group accept responsibility for advertising or editorial content, nor for that appearing on linked third-party websites. Reproduction in whole or in part is forbidden without written permission from BSI Group or Caspian Publishing.
Can your business afford a loss of reputation as the result of an incident?
This was the question that led a recent conference hosted by BSI in partnership with the Royal Geographical Society (with IBG). The topic for discussion was the updated BS 8848 + A1:2009 Specification for the provision of visits, fieldwork, expeditions and adventurous activities outside the United Kingdom.
Lockheed Martin UK - INSYS has achieved certification toBS OHSAS 18001 Occupational health and safety management systems. Certification was achieved following an independent assessment by BSI, against a set of challenging requirements. During a year-long effort, workplace hazards were identified and addressed; and operating procedures were reviewed and updated, with employees receiving tailored training on health and safety disciplines.
Levi Strauss & Co (LS&CO), the global clothing brand, was the first company to put in place a supplier code of conduct (Terms of Engagement - TOE) covering ethical and environmental standards. With products sold through more than 55,000 retail outlets, this was a big step for the organization and its suppliers.
Every year, organizations around the world experience some disruptions to their operations. The reasons can be innocent, from staff illness to weather conditions, but they can also be more severe, from industrial accidents to criminal activity. Whatever the disruption, organizations are under pressure to maintain business as usual. For most, this is helped by the implementation of a business continuity management system (BCMS).
BS 31100 Code of practice for risk management has been published by BSI, establishing principles and terminology for risk management, and offering recommendations for the model, framework, process and implementation of a risk management system.
Question: Do companies need to verify their carbon footprint?
Unless a business is regulated by some form of greenhouse gas (GHG) reporting and/or cap-and-trade regulation (as is the case for some 12,000 installations in Europe), rarely is there the need to either calculate or verify the accuracy of a carbon footprint.
Have a standards-related question for BSI or a comment on the website? We'll find the right person to answer.
